Abstract:Background: Gliomas can be classified into five molecular subgroups based on the status of IDH mutation, 1p/19q codeletion, and TERT promoter mutation, whereas they need to be obtained by biopsy or surgery. We aimed to use MRI-based radiomic approach to noninvasively predict the five molecular subgroups and assess its prognostic value in glioma. Methods: We retrospectively identified 357 patients with grade II-IV gliomas. We extracted radiomic features of tumor and/or edema from preoperative MRI. Features were selected using the least absolute shrinkage and selection operator (LASSO). The predictive model was developed by incorporating preoperative clinical data into the multiparametric MR radiomic signature constructed by machine learning. We compared the prognostic value of predictive molecular subgroups with actual molecular subgroups in predicting progression-free survival (PFS) and overall survival (OS). We developed prognostic nomograms to predict PFS and OS of patients. Findings: Age, tumor location, and LASSO-based multiparametric MR radiomic model yielded the highest performance in predicting IDH mutation status (AUC = 0.855). Decision tree-based multiparametric MR radiomic model performed the best in predicting 1p/19q codeletion (AUC = 0.796) and TERT promoter mutation (AUC = 0.849). The predictive molecular subgroups were comparable to actual molecular subgroups in predicting PFS (C-index: 0.710 vs 0.717, P = 0.890) and OS (C-index: 0.707 vs 0.720, P = 0.630). The prognostic nomograms yielded a C-index of 0.742 and 0.747 in predicting PFS and OS, respectively. Interpretation: Multiparametric MRI-based radiomics with machine learning can be useful for noninvasively detecting molecular subgroups and predicting survival in gliomas.Funding Statement: This work was supported by the National Natural Science Foundation of China (No: 81571664, 81871323, 81801665, 81702465 and U1804172); the National Natural Science Foundation of Guangdong Province (No: 2018B030311024); the Scientific Research General Project of Guangzhou Science Technology and Innovation Commission (No: 201707010328); the China Postdoctoral Science Foundation (No: 2016M600145), the Science and Technology Program of Henan Province (No: 182102310113, 192102310050 and 192102310123), and the Youth Innovation Fund of The First Affiliated Hospital of Zhengzhou University to Zhen-yu Zhang, the Key Research Projects of Henan Higher Education (No: 18A310033). Declaration of Interests: The authors declared no competing interest exists.Ethics Approval Statement: The institutional review board in all participating centers approved this retrospective study and waived the need to obtain written consent.

Integration of MRI radiomics and germline genetics to predict the IDH mutation status of gliomas

Prediction of the Molecular Subtype of IDH Mutation Combined with MGMT Promoter Methylation in Gliomas via Radiomics Based on Preoperative MRI

Predicting IDH Mutation Status in Low-Grade Gliomas Based on Optimal Radiomic Features Combined with Multi-Sequence Magnetic Resonance Imaging

MRI Radiomic Features to Predict IDH1 Mutation Status in Gliomas: A Machine Learning Approach using Gradient Tree Boosting

Using Radiomics Based on Multicenter Magnetic Resonance Images to Predict Isocitrate Dehydrogenase Mutation Status of Gliomas.

Radiomics and Qualitative Features From Multiparametric MRI Predict Molecular Subtypes in Patients With Lower-Grade Glioma

Combining radiomics and deep convolutional neural network features from preoperative MRI for predicting clinically relevant genetic biomarkers in glioblastoma

Quantitative MRI-based Radiomics for Noninvasively Predicting Molecular Subtypes and Survival in Glioma Patients

Radiomics-based prediction of multiple gene alteration incorporating mutual genetic information in glioblastoma and grade 4 astrocytoma, IDH-mutant

Combination of MRI-based prediction and CRISPR/Cas12a-based detection for IDH genotyping in glioma

Radiomics Strategy for Molecular Subtype Stratification of Lower-Grade Glioma: Detecting IDH and TP53 Mutations Based on Multimodal MRI.

Machine learning reveals multimodal MRI patterns predictive of isocitrate dehydrogenase and 1p/19q status in diffuse low- and high-grade gliomas

Qualitative and Quantitative MRI Analysis in IDH1 Genotype Prediction of Lower-Grade Gliomas: A Machine Learning Approach.

Multiregional Radiomics Profiling from Multiparametric MRI: Identifying an Imaging Predictor of IDH1 Mutation Status in Glioblastoma

GlioPredictor: a deep learning model for identification of high-risk adult IDH-mutant glioma towards adjuvant treatment planning

Biological underpinnings of radiomic magnetic resonance imaging phenotypes for risk stratification in IDH wild-type glioblastoma

A radiomics-clinical nomogram for preoperative prediction of IDH1 mutation in primary glioblastoma multiforme.

MRI-based classification of IDH mutation and 1p/19q codeletion status of gliomas using a 2.5D hybrid multi-task convolutional neural network

Automated Machine-Learning Framework Integrating Histopathological and Radiological Information for Predicting IDH1 Mutation Status in Glioma

Radiomics-Based Method for Predicting the Glioma Subtype as Defined by Tumor Grade, IDH Mutation, and 1p/19q Codeletion

MRI Radiomics-Based Molecular Subgrouping and Survival Prediction in Glioma Patients